CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a wide variety of off-label indications and add hundreds of millions of dollars ...
Five patients are now blind after receiving Avastin injections for macular degeneration, according to a New York Times report. Read the full report in Becker’s ASC Review on the Avastin injections.
Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results